Utilization of Nikshay Poshan Yojna in tuberculosis patients in two tuberculosis units of North India

Preeti Sharma; Alok Raina; Kavita Sharma

doi:10.18203/2349-3291.ijcp20230090

Authors

Preeti Sharma Department of Pediatrics, Sub District Hospital, Katra, Jammu and Kashmir, India
Alok Raina Department of Pediatrics, District Hospital, Udhampur, Jammu and Kashmir, India
Kavita Sharma Department of Medicine, District Hospital, Reasi, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20230090

Keywords:

Direct benefit transfer, Tuberculosis, Nutrition, Financial incentive

Abstract

Background: Nikshay Poshan Yojana (NPY) was launched in 2018 aiming to provide nutritional incentive of INR 500 per month to all tuberculosis (TB) patients till they complete their treatment. Aim of present study is to determine the number (proportion) of patients being treated for tuberculosis who received the beneﬁts of NPY and to explore the ways incentives were utilized by the patients.

Methods: This cross-sectional study was conducted in two tuberculosis units of North India from June 2022 to Dec 2022. All newly diagnosed TB patients registered and receiving treatment in these two Units were included in the study. Defaulters, relapse, failure and multidrug-resistant TB cases were excluded. Data was collected from Nikshay portal. All the patients were contacted telephonically to know whether the incentive was utilized for nutrition.

Results: Total 189 patients were included in the study. All patients received benefit under NPY. But only 26 (13.7%) received incentive in scheduled time. Out of 189 patients 56 refused to give telephonic interview about the utilization of incentives. Out of 133 patients who gave interview 85 (64%) patients utilized incentive entirely for nutrition.

Conclusions: Government should assure timely availability of funds so that patients can be benefitted timely particularly during initial months of their treatment. Also, there is a need of counselling of patients receiving treatment for tuberculosis about the importance of nutrition in their treatment so that they can utilize financial incentive for nutrition.

Metrics

Metrics Loading ...

References

Gupta KB, Gupta R, Atreja A, Verma M, Vishvkarma S. Tuberculosis and nutrition. Lung India. Ofﬁcial Organ Indian Chest Society. 2009;26(1):9e16.

WHO. Global Tuberculosis Report 2017. Geneva, Switzerland: WHO; 2017. Available at: https://apps.who.int/iris/handle/10665/259366. Accessed on 24 August 2022.

Lönnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, et al. Tuberculosis control and elimination 2010e50: cure, care, and social development. Lancet. 2010;375:1814-29.

Padmapriyadarsini C, Shobana M, Lakshmi M, Beena T, Swaminathan S. Undernutrition &tuberculosis in India: situation analysis &the way forward. Indian J Med Res. 2016;144(1):11-20.

World Health Organisation. Guideline: Nutritional Care and Support for Patients with Tuberculosis. Geneva: World Health Organisation. 2013.

Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's new end TB strategy. Lancet. 2015;385(9979):1799-801.

Jahnavi G, Sudha CH. Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singap Med J. 2010;51(12):957-62.

Sudarsanam T, John J, Kang G, Mahendri V, Gerrior J, Franciosa M, et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV-tuberculosis coinfection receiving directly observed short-course chemotherapy for tuberculosis. Trop Med Int Health. 2011;16(6):699-706.

Paton NI, Chua YK, Earnest A, Chee CB. Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. Am J Clin Nutr. 2004;80(2):460-5.

Tuberculosis Research Centre. A concurrent comparison of home and sanatorium treatment of tuberculosis in south India. Bull World Health Organ. 1959;21:51-44.

Jeremiah K, Denti P, Chigutsa E, Faurholt-Jepsen D, PrayGod G, Range N, et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients coinfected with HIV. Antimicrobial Agents and Chemotherapy. Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't. 2014;58(6):3468-74.

MoHFW, GoI. National health policy 2017. Available at: https://mohfw.gov.in/sites/default/ ﬁles/9147562941489753121.pdf. Accessed on 24 August 2018.

Direct Benefit Transfer Manual for National Tuberculosis Elimination Programme. New Delhi India: Central TB Divison, MoHfw, Government of India; 2020. Available at: https://www.tbcindia. gov.in. Accessed on 24 August 2022.

Kumar R, Khayyam KU, Singla N, Anand T, Nagaraja SB, Sagili KD, et al. Nikshay Poshan Yojana (NPY) for tuberculosis patients: Early implementation challenges in Delhi, India. Indian J Tuberc. 2020;67(2):231-7.

Begum J, Neelima Y, Ali SI, Pattnaik S, Sharma D. Utilisation of nutritional support scheme among the patients of tuberculosis: A myth or a truth. J Family Med Prim Care. 2020;9(12):6109-14.